Invention Grant
US09546214B2 Humanized antibodies that bind LGR5 有权
结合LGR5的人源化抗体

Humanized antibodies that bind LGR5
Abstract:
Disclosed herein are humanized anti-LGR5 antibodies for the treatment of cancer. Antibodies disclosed herein may bind LGR5 without disrupting LGR5-RSPO1 binding or signaling, and may disrupt LGR5 signaling through Wnt that is independent of RSPO1. Also disclosed are heavy and light chain polypeptide sequences for the biding of LGR5, for example without disrupting LGR5-RSPO binding or signaling.
Public/Granted literature
Information query
Patent Agency Ranking
0/0